Insights from molecular docking and molecular dynamics on the potential of vitexin as an antagonist candidate against lipopolysaccharide (LPS) for microglial activation in neuroinflammation

摘要

Molecular docking visualisation of (A) donepezil and (B) vitexin against TLR4/MD-2 complex by using Biovia Discovery Studio Visualizer. Both ligands docked at the binding pocket of the TLR4/MD-2 complex